Resources

Understanding the Post COVID‑19 Condition (Long COVID) and the Expected Burden for Ontario

Product: — Science Table

Infectious Diseases & Clinical Care

Last Updated: September 14, 2021

The Incidence, Severity, and Management of COVID‑19 in Critically Ill Pregnant Individuals

Product: — Science Table

Infectious Diseases & Clinical Care

Last Updated: September 13, 2021

The Impact of the COVID‑19 Pandemic on Opioid-Related Harm in Ontario

Product: — Science Table

Infectious Diseases & Clinical Care

Last Updated: September 8, 2021

Heparin Anticoagulation for Hospitalized Patients with COVID-19

Product: — Science Table

Infectious Diseases & Clinical Care

Last Updated: September 3, 2021

Response to the Premier of Ontario

Product: — Science Table

Community & Social Services Future Planning Public Health & Implementation Public Health Policy Public Policy & Economic Impact

covid19-sciencetable.ca Last Updated: May 29, 2021

Risk of Vaccine-Induced Thrombotic Thrombocytopenia (VITT) following the AstraZeneca/COVISHIELD Adenovirus Vector COVID‑19 Vaccines

Product: — Science Table

Disease Mechanism Infectious Diseases & Clinical Care Vaccine Vaccines & Immunity

covid19-sciencetable.ca Last Updated: May 11, 2021

Clinical Practice Guidelines Webinar: Tocilizumab

Product: — Science Table

Drug Interventions Healthcare Workers Models Treatments

covid19-sciencetable.ca Last Updated: April 26, 2021

A Vaccination Strategy for Ontario COVID‑19 Hotspots and Essential Workers

Product: — Science Table

Future Planning Models Vaccine Vaccines & Immunity

covid19-sciencetable.ca Last Updated: April 23, 2021

Strategies to Manage Tocilizumab Supply During the COVID‑19 Pandemic

Product: — Science Table

Drug Interventions Future Planning Treatments

covid19-sciencetable.ca Last Updated: April 19, 2021

Thoracic imaging tests for the diagnosis of COVID‐19

Product: — Cochrane Library

Future Planning New Technology

www.cochranelibrary.com Last Updated: March 16, 2021

Also available in Français